BioNTech Is Riding A Wave Of COVID-19 Vaccine Demand, But How Long Will It Last?
Company Will Earn Nearly $20bn In 2021
Pfizer and BioNTech now expect to deliver 2.5 billion doses of Comirnaty this year, putting them far ahead of mRNA vaccine rivals Moderna. • Source: Alamy
